692 related articles for article (PubMed ID: 29349703)
21. Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-β1 from ECM stores.
Schnieder J; Mamazhakypov A; Birnhuber A; Wilhelm J; Kwapiszewska G; Ruppert C; Markart P; Wujak L; Rubio K; Barreto G; Schaefer L; Wygrecka M
Matrix Biol; 2020 Jun; 88():69-88. PubMed ID: 31841706
[TBL] [Abstract][Full Text] [Related]
22. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
23. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.
Hinz B
Curr Rheumatol Rep; 2009 Apr; 11(2):120-6. PubMed ID: 19296884
[TBL] [Abstract][Full Text] [Related]
24. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis.
Hegner B; Schaub T; Catar R; Kusch A; Wagner P; Essin K; Lange C; Riemekasten G; Dragun D
PLoS One; 2016; 11(4):e0153101. PubMed ID: 27054717
[TBL] [Abstract][Full Text] [Related]
26. Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out.
Zent J; Guo LW
Cell Physiol Biochem; 2018; 49(3):848-868. PubMed ID: 30184544
[TBL] [Abstract][Full Text] [Related]
27. Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1.
Mewhort HE; Lipon BD; Svystonyuk DA; Teng G; Guzzardi DG; Silva C; Yong VW; Fedak PW
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H716-24. PubMed ID: 26801303
[TBL] [Abstract][Full Text] [Related]
28. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
[TBL] [Abstract][Full Text] [Related]
29. A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis.
Shiwen X; Stratton R; Nikitorowicz-Buniak J; Ahmed-Abdi B; Ponticos M; Denton C; Abraham D; Takahashi A; Suki B; Layne MD; Lafyatis R; Smith BD
PLoS One; 2015; 10(5):e0126015. PubMed ID: 25955164
[TBL] [Abstract][Full Text] [Related]
30. Host responses in tissue repair and fibrosis.
Duffield JS; Lupher M; Thannickal VJ; Wynn TA
Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
[TBL] [Abstract][Full Text] [Related]
31. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
Beyer C; Dees C; Distler JH
Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
[TBL] [Abstract][Full Text] [Related]
32. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.
Dees C; Pötter S; Zhang Y; Bergmann C; Zhou X; Luber M; Wohlfahrt T; Karouzakis E; Ramming A; Gelse K; Yoshimura A; Jaenisch R; Distler O; Schett G; Distler JH
J Clin Invest; 2020 May; 130(5):2347-2363. PubMed ID: 31990678
[TBL] [Abstract][Full Text] [Related]
33. Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation.
Bernau K; Torr EE; Evans MD; Aoki JK; Ngam CR; Sandbo N
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):465-476. PubMed ID: 28005397
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
35. Matrix abnormalities in pulmonary fibrosis.
Upagupta C; Shimbori C; Alsilmi R; Kolb M
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
[TBL] [Abstract][Full Text] [Related]
36. New developments on skin fibrosis - Essential signals emanating from the extracellular matrix for the control of myofibroblasts.
Schulz JN; Plomann M; Sengle G; Gullberg D; Krieg T; Eckes B
Matrix Biol; 2018 Aug; 68-69():522-532. PubMed ID: 29408278
[TBL] [Abstract][Full Text] [Related]
37. The double-edged role of IL-22 in organ fibrosis.
Chen J; Lodi R; Zhang S; Su Z; Wu Y; Xia L
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):392-399. PubMed ID: 32689851
[TBL] [Abstract][Full Text] [Related]
38. Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy.
Castelino FV; Varga J
Curr Opin Rheumatol; 2014 Nov; 26(6):607-14. PubMed ID: 25191991
[TBL] [Abstract][Full Text] [Related]
39. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.
Pellowe AS; Wu MJ; Kang TY; Chung TD; Ledesma-Mendoza A; Herzog E; Levchenko A; Odell I; Varga J; Gonzalez AL
Am J Pathol; 2024 Jul; 194(7):1171-1184. PubMed ID: 38548268
[TBL] [Abstract][Full Text] [Related]
40. Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation.
Warsinske HC; Ashley SL; Linderman JJ; Moore BB; Kirschner DE
Bull Math Biol; 2015 Aug; 77(8):1556-82. PubMed ID: 26384829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
